Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 9601493, 8 pages
Research Article

Dasatinib and Doxorubicin Treatment of Sarcoma Initiating Cells: A Possible New Treatment Strategy

1Department of Oncology, Aarhus University Hospital, 8000 Aarhus C, Denmark
2Department of Clinical Biochemistry, Aarhus University Hospital, 8000 Aarhus C, Denmark
3Laboratory for Molecular Endocrinology (KMEB), Department of Endocrinology, Odense University Hospital, 5000 Odense, Denmark
4Danish Stem Cell Center (DanStem), Panum Institute, University of Copenhagen, 2200 Copenhagen, Denmark

Received 15 June 2015; Revised 20 August 2015; Accepted 23 August 2015

Academic Editor: Dominik Wolf

Copyright © 2016 Ninna Aggerholm-Pedersen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

1. Supplementary Table 1: gene assays.

2. Supplementary Figure 1: Fold change in growth at different doxorubicin and erlotinib concentrations.

3. Supplementary Figure 2: Quantification of activated RTK.

4. Quantification of Western blot.

  1. Supplementary Material